UMIN-CTR Clinical Trial

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000022756
Receipt No. R000025386
Official scientific title of the study Multicenter randamized study for evaluating the effect of dantrolene aganst heart failure and arrhythmia
Date of disclosure of the study information 2016/06/15
Last modified on 2016/06/15 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Multicenter randamized study for evaluating the effect of dantrolene aganst heart failure and arrhythmia
Title of the study (Brief title) Dantrolene heart failure study
Region
Japan

Condition
Condition heart failure
Classification by specialty
Cardiology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To evaluate the effect of dantrolene aganst heart failure and arrhythmia
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes left ventricular ejection fraction, ocurence of arrhythmia
Key secondary outcomes

In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field.

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control Active
Stratification YES
Dynamic allocation NO
Institution consideration Institution is not considered as adjustment factor.
Blocking NO
Concealment Central registration

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 dantrolene treatment/non-dantrolene treatment
Interventions/Control_2 dantrolene treatment for 2 years
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required.

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
85 years-old >=
Gender Male and Female
Key inclusion criteria 1)Age: from 20 years old to 85 years old
2)Heart disease with/without arrhythmia
3)Patients receive the treatment according to AHA/ACC heart failure guideline
4)Patients gave acceptance for the enrollment to this study
5)in-patients and out-patients can be included in the present study
Key exclusion criteria 1)severe COPD
2)GM
3)severe liver dydfunction
4)ileus
Target sample size 100

Research contact person
Name of lead principal investigator Shigeki Kobayashi
Organization Yamaguchi University Graduate School of Medicine
Division name Division of Cardiology
Address 1-1-1 Minamikogushi, Ube, Yamaguchi, 755-8505, Japan
TEL 0836-22-2248
Email skoba@yamaguchi-u.ac.jp

Public contact
Name of contact person Shigeki Kobayashi
Organization Yamaguchi University Hospital
Division name Division of Cardiology
Address 1-1-1 Minamikogushi, Ube, Yamaguchi, 755-8505, Japan
TEL 0836-22-2248
Homepage URL
Email skoba@yamaguchi-u.ac.jp

Sponsor
Institute Yamaguchi University Graduate School of Medicine
Institute
Department

Sponsor means an organization that is responsible for plan, deployment and
report of the research including funding management. It doesn't mean
funding agency". Therefore, all clinical trial should have the one.

Funding Source
Organization The ministry of education in Japan
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2016 Year 06 Month 15 Day

Progress
Recruitment status Preinitiation
Date of protocol fixation
2016 Year 04 Month 26 Day
Anticipated trial start date
2016 Year 06 Month 24 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2016 Year 06 Month 15 Day
Last modified on
2016 Year 06 Month 15 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025386